219 related articles for article (PubMed ID: 33602785)
1. Loss-of-Function Variants in the Tumor-Suppressor Gene
Olafsdottir T; Stacey SN; Sveinbjornsson G; Thorleifsson G; Norland K; Sigurgeirsson B; Thorisdottir K; Kristjansson AK; Tryggvadottir L; Sarin KY; Benediktsson R; Jonasson JG; Sigurdsson A; Jonasdottir A; Kristmundsdottir S; Jonsson H; Gylfason A; Oddsson A; Fridriksdottir R; Gudjonsson SA; Zink F; Lund SH; Rognvaldsson S; Melsted P; Steinthorsdottir V; Gudmundsson J; Mikaelsdottir E; Olason PI; Stefansdottir L; Eggertsson HP; Halldorsson BV; Thorsteinsdottir U; Agustsson TT; Olafsson K; Olafsson JH; Sulem P; Rafnar T; Gudbjartsson DF; Stefansson K
Cancer Res; 2021 Apr; 81(8):1954-1964. PubMed ID: 33602785
[TBL] [Abstract][Full Text] [Related]
2. PTPN14 Mutations and Cervical Cancer.
Lehrer S; Rheinstein PH
Cancer Diagn Progn; 2021; 1(4):275-277. PubMed ID: 35403138
[TBL] [Abstract][Full Text] [Related]
3. A population-based study of hedgehog pathway gene variants in relation to the dual risk of basal cell carcinoma plus another cancer.
Jorgensen TJ; Ruczinski I; Yao Shugart Y; Wheless L; Berthier Schaad Y; Kessing B; Hoffman-Bolton J; Helzlsouer KJ; Kao WH; Francis L; Alani RM; Strickland PT; Smith MW; Alberg AJ
Cancer Epidemiol; 2012 Oct; 36(5):e288-93. PubMed ID: 22677152
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?
Roberts MR; Asgari MM; Toland AE
Br J Dermatol; 2019 Dec; 181(6):1146-1155. PubMed ID: 30908599
[TBL] [Abstract][Full Text] [Related]
5. Combined analysis of keratinocyte cancers identifies novel genome-wide loci.
Liyanage UE; Law MH; Han X; An J; Ong JS; Gharahkhani P; Gordon S; Neale RE; Olsen CM; ; MacGregor S; Whiteman DC
Hum Mol Genet; 2019 Sep; 28(18):3148-3160. PubMed ID: 31174203
[TBL] [Abstract][Full Text] [Related]
6. Large-scale Sequencing of Testicular Germ Cell Tumour (TGCT) Cases Excludes Major TGCT Predisposition Gene.
Litchfield K; Loveday C; Levy M; Dudakia D; Rapley E; Nsengimana J; Bishop DT; Reid A; Huddart R; Broderick P; Houlston RS; Turnbull C
Eur Urol; 2018 Jun; 73(6):828-831. PubMed ID: 29433971
[TBL] [Abstract][Full Text] [Related]
7. Understanding the Molecular Genetics of Basal Cell Carcinoma.
Pellegrini C; Maturo MG; Di Nardo L; Ciciarelli V; Gutiérrez García-Rodrigo C; Fargnoli MC
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165358
[TBL] [Abstract][Full Text] [Related]
8. Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.
Stacey SN; Sulem P; Gudbjartsson DF; Jonasdottir A; Thorleifsson G; Gudjonsson SA; Masson G; Gudmundsson J; Sigurgeirsson B; Benediktsdottir KR; Thorisdottir K; Ragnarsson R; Fuentelsaz V; Corredera C; Grasa M; Planelles D; Sanmartin O; Rudnai P; Gurzau E; Koppova K; Hemminki K; Nexø BA; Tjønneland A; Overvad K; Johannsdottir H; Helgadottir HT; Thorsteinsdottir U; Kong A; Vogel U; Kumar R; Nagore E; Mayordomo JI; Rafnar T; Olafsson JH; Stefansson K
Hum Mol Genet; 2014 Jun; 23(11):3045-53. PubMed ID: 24403052
[TBL] [Abstract][Full Text] [Related]
9. Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.
Pritchard AL; Johansson PA; Nathan V; Howlie M; Symmons J; Palmer JM; Hayward NK
PLoS One; 2018; 13(4):e0194098. PubMed ID: 29641532
[TBL] [Abstract][Full Text] [Related]
10. Genetic and functional interaction network analysis reveals global enrichment of regulatory T cell genes influencing basal cell carcinoma susceptibility.
Adolphe C; Xue A; Fard AT; Genovesi LA; Yang J; Wainwright BJ
Genome Med; 2021 Feb; 13(1):19. PubMed ID: 33549134
[TBL] [Abstract][Full Text] [Related]
11. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
12. A germline variant in the interferon regulatory factor 4 gene as a novel skin cancer risk locus.
Han J; Qureshi AA; Nan H; Zhang J; Song Y; Guo Q; Hunter DJ
Cancer Res; 2011 Mar; 71(5):1533-9. PubMed ID: 21270109
[TBL] [Abstract][Full Text] [Related]
13. Host phenotype characteristics and MC1R in relation to early-onset basal cell carcinoma.
Ferrucci LM; Cartmel B; Molinaro AM; Gordon PB; Leffell DJ; Bale AE; Mayne ST
J Invest Dermatol; 2012 Apr; 132(4):1272-9. PubMed ID: 22158557
[TBL] [Abstract][Full Text] [Related]
14. Frequent basal cell cancer development is a clinical marker for inherited cancer susceptibility.
Cho HG; Kuo KY; Li S; Bailey I; Aasi S; Chang ALS; Oro AE; Tang JY; Sarin KY
JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089731
[TBL] [Abstract][Full Text] [Related]
15. Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma.
Bonilla X; Parmentier L; King B; Bezrukov F; Kaya G; Zoete V; Seplyarskiy VB; Sharpe HJ; McKee T; Letourneau A; Ribaux PG; Popadin K; Basset-Seguin N; Ben Chaabene R; Santoni FA; Andrianova MA; Guipponi M; Garieri M; Verdan C; Grosdemange K; Sumara O; Eilers M; Aifantis I; Michielin O; de Sauvage FJ; Antonarakis SE; Nikolaev SI
Nat Genet; 2016 Apr; 48(4):398-406. PubMed ID: 26950094
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.
Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG
Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957
[TBL] [Abstract][Full Text] [Related]
17. A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype.
Mirshahi UL; Kim J; Best AF; Chen ZE; Hu Y; Haley JS; Golden A; Stahl R; Manickam K; Carr AG; Harney LA; Field A; Hatton J; Schultz KAP; Bauer AJ; Hill DA; Rosenberg PS; Murray MF; Carey DJ; Stewart DR
JAMA Netw Open; 2021 Feb; 4(2):e210112. PubMed ID: 33630087
[TBL] [Abstract][Full Text] [Related]
18. The role of TP53 and MDM2 polymorphisms in TP53 mutagenesis and risk of non-melanoma skin cancer.
Almquist LM; Karagas MR; Christensen BC; Welsh MM; Perry AE; Storm CA; Nelson HH
Carcinogenesis; 2011 Mar; 32(3):327-30. PubMed ID: 21123835
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.
Johansson PA; Nathan V; Bourke LM; Palmer JM; Zhang T; Symmons J; Howlie M; Patch AM; Read J; Holland EA; Schmid H; Warrier S; Glasson W; Höiom V; Wadt K; Jönsson G; Olsson H; Ingvar C; Mann G; Brown KM; Hayward NK; Pritchard AL
Melanoma Res; 2019 Oct; 29(5):483-490. PubMed ID: 31464824
[TBL] [Abstract][Full Text] [Related]
20. Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing.
Artomov M; Stratigos AJ; Kim I; Kumar R; Lauss M; Reddy BY; Miao B; Daniela Robles-Espinoza C; Sankar A; Njauw CN; Shannon K; Gragoudas ES; Marie Lane A; Iyer V; Newton-Bishop JA; Timothy Bishop D; Holland EA; Mann GJ; Singh T; Daly MJ; Tsao H
J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29522175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
